These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28213517)

  • 1. The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response.
    Zhang A; Peng B; Huang P; Chen J; Gong Z
    J Biol Chem; 2017 Apr; 292(16):6461-6467. PubMed ID: 28213517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIRR regulates 53BP1 by masking its histone methyl-lysine binding function.
    Drané P; Brault ME; Cui G; Meghani K; Chaubey S; Detappe A; Parnandi N; He Y; Zheng XF; Botuyan MV; Kalousi A; Yewdell WT; Münch C; Harper JW; Chaudhuri J; Soutoglou E; Mer G; Chowdhury D
    Nature; 2017 Mar; 543(7644):211-216. PubMed ID: 28241136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR.
    Dai Y; Zhang A; Shan S; Gong Z; Zhou Z
    Nat Commun; 2018 May; 9(1):2123. PubMed ID: 29844495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs.
    Parnandi N; Rendo V; Cui G; Botuyan MV; Remisova M; Nguyen H; Drané P; Beroukhim R; Altmeyer M; Mer G; Chowdhury D
    Mol Cell; 2021 Jun; 81(12):2583-2595.e6. PubMed ID: 33961797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociation.
    Ketley RF; Battistini F; Alagia A; Mondielli C; Iehl F; Balikçi E; Huber KVM; Orozco M; Gullerova M
    Cell Rep; 2022 Oct; 41(4):111526. PubMed ID: 36288694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1.
    Zhang F; Gong Z
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):38-46. PubMed ID: 33448186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nudix Hydrolase NUDT16 Regulates 53BP1 Protein by Reversing 53BP1 ADP-Ribosylation.
    Zhang F; Lou L; Peng B; Song X; Reizes O; Almasan A; Gong Z
    Cancer Res; 2020 Mar; 80(5):999-1010. PubMed ID: 31911551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells.
    Tang M; Chen Z; Wang C; Feng X; Lee N; Huang M; Zhang H; Li S; Xiong Y; Chen J
    J Biol Chem; 2022 Jun; 298(6):101979. PubMed ID: 35472331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the inhibition of the methyl-lysine binding function of 53BP1 by TIRR.
    Wang J; Yuan Z; Cui Y; Xie R; Yang G; Kassab MA; Wang M; Ma Y; Wu C; Yu X; Liu X
    Nat Commun; 2018 Jul; 9(1):2689. PubMed ID: 30002377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function.
    Tang M; Feng X; Pei G; Srivastava M; Wang C; Chen Z; Li S; Zhang H; Zhao Z; Li X; Chen J
    Cell Rep; 2020 Aug; 32(6):108018. PubMed ID: 32783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation of 53BP1 dictates the DNA double strand break repair pathway.
    Guo X; Bai Y; Zhao M; Zhou M; Shen Q; Yun CH; Zhang H; Zhu WG; Wang J
    Nucleic Acids Res; 2018 Jan; 46(2):689-703. PubMed ID: 29190394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDGFRP3 interaction with 53BP1 promotes DNA double-strand break repair.
    Zhang Z; Samsa WE; De Y; Zhang F; Reizes O; Almasan A; Gong Z
    Nucleic Acids Res; 2023 Mar; 51(5):2238-2256. PubMed ID: 36794849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.
    Fukuda T; Wu W; Okada M; Maeda I; Kojima Y; Hayami R; Miyoshi Y; Tsugawa K; Ohta T
    Cancer Sci; 2015 Aug; 106(8):1050-6. PubMed ID: 26053117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
    Xu G; Chapman JR; Brandsma I; Yuan J; Mistrik M; Bouwman P; Bartkova J; Gogola E; Warmerdam D; Barazas M; Jaspers JE; Watanabe K; Pieterse M; Kersbergen A; Sol W; Celie PHN; Schouten PC; van den Broek B; Salman A; Nieuwland M; de Rink I; de Ronde J; Jalink K; Boulton SJ; Chen J; van Gent DC; Bartek J; Jonkers J; Borst P; Rottenberg S
    Nature; 2015 May; 521(7553):541-544. PubMed ID: 25799992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in.
    Mirman Z; Lottersberger F; Takai H; Kibe T; Gong Y; Takai K; Bianchi A; Zimmermann M; Durocher D; de Lange T
    Nature; 2018 Aug; 560(7716):112-116. PubMed ID: 30022158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHAMP1-POGZ counteracts the inhibitory effect of 53BP1 on homologous recombination and affects PARP inhibitor resistance.
    Fujita H; Ikeda M; Ui A; Ouchi Y; Mikami Y; Kanno SI; Yasui A; Tanaka K
    Oncogene; 2022 May; 41(19):2706-2718. PubMed ID: 35393543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of DNA repair in the absence of classical non-homologous end joining.
    Kang YJ; Yan CT
    DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.
    Gupta R; Somyajit K; Narita T; Maskey E; Stanlie A; Kremer M; Typas D; Lammers M; Mailand N; Nussenzweig A; Lukas J; Choudhary C
    Cell; 2018 May; 173(4):972-988.e23. PubMed ID: 29656893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shieldin complex mediates 53BP1-dependent DNA repair.
    Noordermeer SM; Adam S; Setiaputra D; Barazas M; Pettitt SJ; Ling AK; Olivieri M; Álvarez-Quilón A; Moatti N; Zimmermann M; Annunziato S; Krastev DB; Song F; Brandsma I; Frankum J; Brough R; Sherker A; Landry S; Szilard RK; Munro MM; McEwan A; Goullet de Rugy T; Lin ZY; Hart T; Moffat J; Gingras AC; Martin A; van Attikum H; Jonkers J; Lord CJ; Rottenberg S; Durocher D
    Nature; 2018 Aug; 560(7716):117-121. PubMed ID: 30022168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
    Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
    Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.